PL4522144T3 - Kompozycja zawierająca kreatynę do stosowania w leczeniu trudności w oddychaniu - Google Patents

Kompozycja zawierająca kreatynę do stosowania w leczeniu trudności w oddychaniu

Info

Publication number
PL4522144T3
PL4522144T3 PL23726112.8T PL23726112T PL4522144T3 PL 4522144 T3 PL4522144 T3 PL 4522144T3 PL 23726112 T PL23726112 T PL 23726112T PL 4522144 T3 PL4522144 T3 PL 4522144T3
Authority
PL
Poland
Prior art keywords
creatine
treatment
composition
breathing difficulties
breathing
Prior art date
Application number
PL23726112.8T
Other languages
English (en)
Inventor
Jürgen BEZLER
Verena Löber
Robert Alber
Sergej M. OSTOJIC
Original Assignee
Alzchem Trostberg Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP22172901.5A external-priority patent/EP4275680A1/en
Priority claimed from EP22187487.8A external-priority patent/EP4311549A1/en
Application filed by Alzchem Trostberg Gmbh filed Critical Alzchem Trostberg Gmbh
Publication of PL4522144T3 publication Critical patent/PL4522144T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL23726112.8T 2022-05-12 2023-05-11 Kompozycja zawierająca kreatynę do stosowania w leczeniu trudności w oddychaniu PL4522144T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP22172901.5A EP4275680A1 (en) 2022-05-12 2022-05-12 Composition comprising creatine for use in the treatment of breathing difficulties
EP22187487.8A EP4311549A1 (en) 2022-07-28 2022-07-28 Composition comprising creatine for use in the treatment of post viral fatigue syndrome
EP23154842 2023-02-03
EP23154844 2023-02-03
PCT/EP2023/062670 WO2023217993A1 (en) 2022-05-12 2023-05-11 Composition comprising creatine for use in the treatment of breathing difficulties

Publications (1)

Publication Number Publication Date
PL4522144T3 true PL4522144T3 (pl) 2026-05-11

Family

ID=86558783

Family Applications (1)

Application Number Title Priority Date Filing Date
PL23726112.8T PL4522144T3 (pl) 2022-05-12 2023-05-11 Kompozycja zawierająca kreatynę do stosowania w leczeniu trudności w oddychaniu

Country Status (7)

Country Link
US (2) US20250325505A1 (pl)
EP (2) EP4522144B1 (pl)
JP (2) JP7781310B2 (pl)
CN (2) CN119173259A (pl)
ES (1) ES3064989T3 (pl)
PL (1) PL4522144T3 (pl)
WO (2) WO2023217994A1 (pl)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160137528A (ko) * 2014-02-07 2016-11-30 유니버시티 오브 유타 리서치 파운데이션 크레아틴, 오메가-3 지방산 및 시티콜린의 조합
GB2596849A (en) * 2020-07-10 2022-01-12 Jardine Romy Nutritional supplement composition for treating coronavirus infections, cancer, ME, post viral & Chronic fatigue syndrome & neurodegeneration in an individual

Also Published As

Publication number Publication date
WO2023217994A1 (en) 2023-11-16
ES3064989T3 (en) 2026-04-30
EP4522144A1 (en) 2025-03-19
WO2023217993A1 (en) 2023-11-16
EP4522144B1 (en) 2026-03-11
JP7781310B2 (ja) 2025-12-05
JP7781309B2 (ja) 2025-12-05
EP4522145A1 (en) 2025-03-19
EP4522144C0 (en) 2026-03-11
CN119173259A (zh) 2024-12-20
CN119255795A (zh) 2025-01-03
JP2025515582A (ja) 2025-05-20
US20250302788A1 (en) 2025-10-02
JP2025515584A (ja) 2025-05-20
US20250325505A1 (en) 2025-10-23

Similar Documents

Publication Publication Date Title
IL297849B1 (en) Composition for use in the treatment of APOL1-related disease
IL315901A (en) 5-MEO-DMT for use in the treatment of sleep disorders
IL315897A (en) 5-MEO-DMT for use in the treatment of sleep disorders
ZA202307970B (en) Compounds for use in the treatment and prevention of covid- 19
PL4340842T3 (pl) Sotorasib do zastosowania w leczeniu nowotworów
CA3264923A1 (en) COMPOSITION INTENDED FOR USE IN THE TREATMENT OF FABRY'S DISEASE
EP4445914A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF TUMORS AND USE
EP3960167A4 (en) Use of pantothenic acid in preparation composition for treating and/or preventing tumors
PL3773615T3 (pl) Płynna kompozycja do stosowania w leczeniu błony śluzowej przewodu ustno-gardłowo-krtaniowo-przełykowego
LT4048229T (lt) Farmacinė kompozicija, skirta panaudoti įvairių etiologijų cistito gydymui
IL282718A (en) Compounds for use in the treatment or prevention of pain, inflammation and/or autoimmune diseases
IL284980B1 (en) Heteroaryl-azacyclic-oxo-amide compound, pharmaceutical preparation and pharmaceutical preparation for use in the treatment
PL3937949T3 (pl) Fitoekdyzony i ich pochodne do ich zastosowania w leczeniu upośledzenia funkcji oddechowych
IL314205A (en) Ramibrutinib for use in the treatment of hidradenitis suppurativa
IL288307A (en) Preparations for use in the treatment of insulin deficiency conditions
IL297398B2 (en) Pharmaceutical preparation containing L-triiodothyronine (T3) for use in the treatment of tissue hypoxia and sepsis
IL315893A (en) 5-MEO-DMT for use in the treatment of postpartum depression
IL327100A (en) Alsonarsen/PRAX-22 for use in the treatment of SCN2A-related disorders
GB2610895B (en) Composition for use in the treatment and/or prevention of mycotoxic disease
GB202202541D0 (en) Composition for use in the treatment and/or prevention of mycotoxic disease
HK40088920A (en) Methylthioninium compounds for use in the treatment of covid-19
HK40087864A (en) Methylthioninium compounds for use in the treatment of covid-19
CA3302321A1 (en) Compounds for use in the treatment of phenylketonuria
GB202213305D0 (en) Compositions for use in the treatment of diabetes or obesity
PL3738596T3 (pl) Związek i kompozycja do stosowania w leczeniu zespołu napięcia przedmiesiączkowego i/lub przedmiesiączkowego zaburzenia dysforycznego